Filing Details

Accession Number:
0001209191-19-011991
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-21 16:21:00
Reporting Period:
2019-02-19
Accepted Time:
2019-02-21 16:21:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550395 David Altshuler C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Global Research And Cso No Yes No No
Transaction Summary
Sold: 5,624 shares Avg. Price: $187.00 Total Value: $1,051,715.53
Number of Shares After Transactions: 31,553 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-02-19 4,573 $186.81 32,604 No 4 S Direct
Common Stock Disposition 2019-02-19 651 $187.40 31,953 No 4 S Direct
Common Stock Disposition 2019-02-19 400 $188.59 31,553 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $186.81 (range $186.09 to $187.08).
  3. Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $187.40 (range $187.12 to $187.96).
  5. Open market sales reported on this line occurred at a weighted average price of $188.59 (range $188.36 to $188.86).